American Oncology Network Inc Quick Ratio (AONC) starting from the fourth quarter 2024 to fourth quarter 2023, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


American Oncology Network Inc   (AONC)

American Oncology Network Inc 's Quick Ratio

AONC's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


American Oncology Network Inc 's Cash & cash equivalent grew by 273.82 % in the Q4 2024 sequentially, faster than Current Liabilities, this led to improvement in American Oncology Network Inc 's Quick Ratio to 0.33, Quick Ratio remained below American Oncology Network Inc average.

Within Medical Equipment & Supplies industry 169 other companies have achieved higher Quick Ratio than American Oncology Network Inc in fourth quarter 2024. While Quick Ratio total ranking has improved so far during the Q4 2024 to 3289, from total ranking in the third quarter 2024 at 3388.

Explain Quick Ratio?
How much Cash & cash equivalents AONC´s has?
What are AONC´s Current Liabilities?




AONC Quick Ratio (Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
(Mar 31 2024)
Q1
(Dec 31 2023)
Q4
Y / Y Current Liabilities Change 28.28 % 19.03 % 2578.79 % 3174.23 % 2164.2 %
Y / Y Cash & cash equivalent Change 13.63 % -74.99 % 2700927.4 % 2642642.14 % 137.42 %
Quick Ratio MRQ 0.33 0.1 0.24 0.45 0.38
AONC's Total Ranking # 3289 # 3388 # 2298 # 2249 # 2065
Seq. Current Liabilities Change 8.5 % -13.69 % -0.97 % 38.32 % 0.68 %
Seq. Cash & cash equivalent Change 273.82 % -64.8 % -47.44 % 64.32 % -17.71 %



Quick Ratio fourth quarter 2024 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 170
Healthcare Sector # 891
Overall Market # 3289


Quick Ratio Statistics
High Average Low
9.77 1.25 0
(Jun 30 2021)   (Jun 30 2023)




Financial Statements
American Oncology Network Inc 's Current Liabilities $ 217 Millions Visit AONC's Balance sheet
American Oncology Network Inc 's Cash & cash equivalent $ 73 Millions Visit AONC's Balance sheet
Source of AONC's Sales Visit AONC's Sales by Geography


Cumulative American Oncology Network Inc 's Quick Ratio

AONC's Quick Ratio for the trailling 12 Months

AONC Quick Ratio

(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth 150.07 % 336.44 % 3094.05 % 3244.14 % 3056.49 %
Y / Y Cash & cash equivalent TTM Growth 78.17 % 132.86 % 1011.33 % 798.54 % 405.27 %
Quick Ratio TTM 0.29 0.29 0.38 0.43 0.4
Total Ranking TTM # 3743 # 3754 # 3721 # 3712 # 1628
Seq. Current Liabilities TTM Growth 5.73 % 3.98 % 38.47 % 64.27 % 84.53 %
Seq. Cash & cash equivalent TTM Growth 3.58 % -19.3 % 22.38 % 74.17 % 35.37 %


On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q4 2024 to $216.85 millions, cumulative Quick Ratio remained unchanged at 0.29 below the American Oncology Network Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 209 other companies have achieved higher Quick Ratio than American Oncology Network Inc . While Quick Ratio overall ranking has improved so far to 3743, from total ranking during the twelve months ending third quarter 2024 at 3754.

Explain Quick Ratio?
How much Cash & cash equivalents AONC´s has?
What are AONC´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 210
Healthcare Sector # 944
Within the Market # 3743


trailing twelve months Quick Ratio Statistics
High Average Low
2.18 0.56 0.03
(Dec 31 2021)   (Jun 30 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2024, within Medical Equipment & Supplies Industry Quick RatioDec 31 2024 MRQ Cash & cash equivalentDec 31 2024 MRQ Current Liabilities
West Pharmaceutical Services Inc   0.88 $ 484.600  Millions$ 550.400  Millions
Milestone Scientific Inc   0.87 $ 3.258  Millions$ 3.744  Millions
Lucid Diagnostics Inc   0.85 $ 22.358  Millions$ 26.353  Millions
Stryker Corp  0.84 $ 4,540.000  Millions$ 5,379.000  Millions
Sonoma Pharmaceuticals Inc   0.84 $ 3.128  Millions$ 3.719  Millions
Angiodynamics Inc   0.83 $ 76.056  Millions$ 91.155  Millions
Trisalus Life Sciences Inc   0.83 $ 8.525  Millions$ 10.228  Millions
Allurion Technologies Inc   0.82 $ 15.379  Millions$ 18.863  Millions
Artivion Inc   0.80 $ 53.463  Millions$ 66.823  Millions
Neuroone Medical Technologies Corp  0.78 $ 1.960  Millions$ 2.497  Millions
Vaso Corporation  0.76 $ 26.271  Millions$ 34.720  Millions
Medtronic Plc  0.74 $ 8,005.000  Millions$ 10,789.000  Millions
Innovage Holding Corp   0.74 $ 102.779  Millions$ 138.599  Millions
Nexgel Inc   0.73 $ 1.807  Millions$ 2.470  Millions
Paragon 28 inc   0.72 $ 34.580  Millions$ 48.134  Millions
Embecta Corp   0.72 $ 267.500  Millions$ 374.000  Millions
Align Technology inc   0.71 $ 1,043.887  Millions$ 1,471.050  Millions
Neuronetics Inc   0.70 $ 18.459  Millions$ 26.474  Millions
Pro dex Inc   0.70 $ 6.848  Millions$ 9.845  Millions
Avanos Medical Inc   0.69 $ 107.700  Millions$ 155.000  Millions
Lifestance Health Group Inc   0.68 $ 154.571  Millions$ 228.886  Millions
Sanara Medtech Inc   0.67 $ 16.878  Millions$ 25.018  Millions
Msa Safety Inc  0.67 $ 164.560  Millions$ 246.991  Millions
Haemonetics Corporation  0.60 $ 178.800  Millions$ 300.383  Millions
Star Equity Holdings Inc   0.59 $ 7.371  Millions$ 12.470  Millions
Teleflex Incorporated  0.59 $ 247.852  Millions$ 421.302  Millions
Docgo Inc   0.59 $ 89.242  Millions$ 151.807  Millions
Sonendo Inc   0.58 $ 11.627  Millions$ 19.939  Millions
Edap Tms Sa  0.57 $ 30.995  Millions$ 53.989  Millions
Stereotaxis Inc   0.57 $ 12.217  Millions$ 21.602  Millions

Date modified: 2026-09-08T15:11:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.